Papers
12
Total Citations
377
H-Index
9
About
Dr. Jeffrey How is a leading figure in gynecologic oncology, renowned for pioneering the integration of robotic surgery into the management of gynecologic cancers. His research centers on surgical innovation, patient outcomes, and quality of life, with a particular focus on endometrial, ovarian, and cervical cancers. Dr. How’s seminal prospective study on sentinel lymph node detection for endometrial cancer (82 citations) established a critical benchmark for minimally invasive staging. He has consistently demonstrated the safety and efficacy of robotic techniques across diverse populations, notably showing improved outcomes for elderly patients (76 citations) and those undergoing neoadjuvant chemotherapy for ovarian cancer (43 citations). His work also addresses critical clinical challenges, such as vaginal vault dehiscence (48 citations), and provides rigorous cost-effectiveness analyses (32 citations). Beyond survival metrics, Dr. How is a pioneer in patient-centered research, publishing some of the earliest prospective quality-of-life and postoperative pain satisfaction studies following robotic surgery. With over 370 combined citations, his work has fundamentally shaped the shift toward robotically-assisted surgical interfaces, improving both clinical outcomes and the patient experience in gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Vaginal Vault Dehiscence After Robotic Hysterectomy for Gynecologic Cancers48 citations · 2013
- 4
- 5
- 6Robotic radical hysterectomy: comparison of outcomes and cost32 citations · 2010
- 7
- 8
- 9Health-Related Quality of Life Following Robotic Surgery: A Pilot Study11 citations · 2014
- 10